Tue, October 31, 2023

Kristen Kluska Downgraded (SRPT) to Hold and Decreased Target to $40 on, Oct 31st, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-40-on-oct-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Kristen Kluska of Cantor Fitzgerald, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $166 to $40 on, Oct 31st, 2023.

Kristen has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Kristen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kristen


  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023